Cryoport
NASDAQ: CYRXLake Forest, US · Nevada corporation
Find your way into Cryoport
391 people in our graph share verified history with the Cryoport team — schools, employers, funds. One of them is your warm intro.
Steve Gillanunlockedknows Robert Stefanovich · together at Raychem (overlapped)
×6knows the team · via Raychem
knows the team · via SAIC
×4knows the team · via Technische Universität Darmstadt
Cryoport provides temperature-controlled supply chain solutions, cryogenic storage systems, and biostorage and sample processing services for the Life Sciences industry, with a focus on cell and gene therapy. It serves biopharmaceutical, animal husbandry, and reproductive medicine companies, as well as universities, research institutions, and government agencies across the Americas, EMEA, and APAC.
Founders & leadership
RS
Robert StefanovichExecutiveRobert Stefanovich is an executive with extensive financial management and business leadership experience across life sciences and hi-tech organizations, ranging from startups to Fortune 500 companies. He has a background in public accounting and has managed strategic planning, fundraising, mergers and acquisitions, and SEC compliance for both publicly traded and privately held entities.
JW

Jerrell W. SheltonPresident, Chief Executive Officer and Chairman of the Board
MS

EJ
Edward J. ZecchiniChief Digital and Technology Officer
Board
RM
Ramkumar MandalamBoard director
RR
Richard RathmannBoard director
RB
Richard BermanBoard director
Reported raises · per SEC filings
Form D private placements$29.2M disclosed across 5 rounds · 2014–2018
▶$25MraisedDec 2018 · 1 investors · BiotechnologyRule 506(b)
▶$25MraisedDec 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jerrell W SheltonExecutive Officer, Director
- Richard J BermanDirector
- Edward ZecchiniDirector
- Ramkumar MandalamDirector
- Robert S. StefanovichExecutive Officer
- Robert HaririDirector
- Offering amount
- $25M
- Amount sold
- $25M
- First sale
- Dec 2018
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$2.5MraisedApr 2016 · 192 investors · BiotechnologyRule 506(b)
▶$2.5MraisedApr 2016 · 192 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert S. StefanovichExecutive Officer
- Ramkumar MandalamDirector
- Robert HaririDirector
- Jerrell W SheltonExecutive Officer, Director
- Edward ZecchiniDirector
- Richard J BermanDirector
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- Sales commissions
- $156K
- Placement agents
- Emergent Financial Group, Inc.
- First sale
- Apr 2016
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$46.2KraisedMar 2016 · 3 investors · BiotechnologyRule 506(b)
▶$46.2KraisedMar 2016 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ramkumar MandalamDirector
- Robert S. StefanovichExecutive Officer
- Richard J BermanDirector
- Jerrell W SheltonExecutive Officer, Director
- Edward ZecchiniDirector
- Robert HaririDirector
- Offering amount
- $46.2K
- Amount sold
- $46.2K
- First sale
- Mar 2016
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$50KraisedMar 2015 · 1 investors · BiotechnologyRule 506(b)
▶$50KraisedMar 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ramkumar MandalamDirector
- Richard RathmannDirector
- Richard BermanDirector
- Jerrell SheltonExecutive Officer, Director
- Robert StefanovichExecutive Officer
- Edward ZecchiniDirector
- Offering amount
- $4.8M
- Amount sold
- $50K
- Sales commissions
- $6.5K
- Placement agents
- Emergent Financial Group, Inc.
- First sale
- Feb 2015
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$1.6MraisedMay 2014 · 32 investors · BiotechnologyRule 506(b)
▶$1.6MraisedMay 2014 · 32 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert StefanovichExecutive Officer
- Offering amount
- $9.6M
- Amount sold
- $1.6M
- Sales commissions
- $89.6K
- Placement agents
- Emergent Financial Group, Inc.
- First sale
- May 2014
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Cryoport do?
- Cryoport provides temperature-controlled supply chain solutions, cryogenic storage systems, and biostorage and sample processing services for the Life Sciences industry, with a focus on cell and gene therapy. It serves biopharmaceutical, animal husbandry, and reproductive medicine companies, as well as universities, research institutions, and government agencies across the Americas, EMEA, and APAC.
- How much funding has Cryoport raised?
- Cryoport has disclosed $29.2M raised across 5 rounds.
- Where is Cryoport headquartered?
- Cryoport is headquartered in Lake Forest, US.
